SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential.
Liang X, Liu Y, Jia S, Zhang K, Xu J.
Cystic fibrosis (CF) is a life-threatening autosomal recessive disease caused by loss-of-function mutations in the CF transmembrane conductance regulator (CFTR) gene. Although highly effective CFTR modulator therapies (HEMT) have transformed outcomes for many ...